Beyond the canonical Aβ and tau pathologies, emerging evidence highlights the roles of proteins like sortilin and clusterin in amyloid processing, clearance, and neuroprotection, rendering them compelling targets for comprehensive AD therapy [4]. This evidence concerns the gene MAPT and Alzheimer disease.